Heterozygous ABCC8 mutations are a cause of MODY
The ABCC8 gene encodes the sulfonylurea receptor 1 (SUR1) subunit of the pancreatic beta cell ATP-sensitive potassium (KATP) channel. Inactivating mutations cause congenital hyperinsulinism (CHI) and activating mutations cause transient neonatal diabetes (TNDM) or permanent neonatal diabetes (PNDM) that can usually be treated with sulfonylureas. Sulfonylurea sensitivity is also a feature of HNF1A and HNF4A MODY, but patients referred for genetic testing with clinical features of these types of diabetes do not always have mutations in the HNF1A/4A genes. Our aim was to establish whether mutations in the ABCC8 gene cause MODY that is responsive to sulfonylurea therapy.
We sequenced the ABCC8 gene in 85 patients with a BMI <30 kg/m2, no family history of neonatal diabetes and who were deemed sensitive to sulfonylureas by the referring clinician or were sulfonylurea-treated. All had tested negative for mutations in the HNF1A and HNF4A genes.
ABCC8 mutations were found in seven of the 85 (8%) probands. Four patients were heterozygous for previously reported mutations and four novel mutations, E100K, G214R, Q485R and N1245D, were identified. Only four probands fulfilled MODY criteria, with two diagnosed after 25 years and one patient, who had no family history of diabetes, as a result of a proven de novo mutation.
ABCC8 mutations can cause MODY in patients whose clinical features are similar to those with HNF1A/4A MODY. Therefore, sequencing of ABCC8 in addition to the known MODY genes should be considered if such features are present, to facilitate optimal clinical management of these patients.
Supplementary Material (0)
- Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K (2009) Hyperinsulinaemic hypoglycaemia. Arch Dis Child 94:450–457 CrossRef
- Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838–1849 CrossRef
- Flanagan SE, Patch AM, Mackay DJ et al (2007) Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 56:1930–1937 CrossRef
- Babenko AP, Polak M, Cave H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456–466 CrossRef
- Ellard S, Flanagan SE, Girard CA et al (2007) Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 81:375–382 CrossRef
- Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT (2008) Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31:204–209 CrossRef
- Tarasov AI, Nicolson TJ, Riveline JP et al (2008) A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults. Diabetes 57:1595–1604 CrossRef
- Hartemann-Heurtier A, Simon A, Bellanne-Chantelot C et al (2009) Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes. Diabetes Metab 35:233–235 CrossRef
- Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504–2508 CrossRef
- Bonnefond A, Durand E, Sand O et al (2010) Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome. PLoS One 5:e13630 CrossRef
About this Article
- Heterozygous ABCC8 mutations are a cause of MODY
Volume 55, Issue 1 , pp 123-127
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Diabetes mellitus
- KATP channels
- Industry Sectors
- Author Affiliations
- 1. Peninsula NIHR Clinical Research Facility, Peninsula Medical School, University of Exeter, Exeter, UK
- 2. Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter, Exeter, UK
- 3. Department of Molecular Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter, EX2 5AD, UK
- 4. Department of Diabetes and Endocrinology, Torbay Hospital, Devon, UK